Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Solvay

Status: Completed

Conditions: Hypertension; Type 2 Diabetes

Treatments: Drug: eprosartan/HCTZ

Study type: Interventional

Funder types: Industry

Identifiers

NCT00160160

S171.3.012

2004-00703-18

Details and patient eligibility

About

This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.

Sex: All

Ages: 40 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• essential hypertension,
• diabetes type 2

Exclusion criteria

• severe cardiovascular disease,
• grade 3 hypertension,
• secondary hypertension,
• abnormal liver enzymes

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind